Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026)
Johnson & Johnson (JNJ) posted Dividends Paid - Common of $3.1 billion for Q1 2026, little changed sequentially from $3.1 billion in Q4 2025, and up 4.75% YoY from $3.0 billion in Q1 2025.
Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 18 years of Dividends Paid - Common data on file, last reported at $3.1 billion in Q1 2026.
- Quarterly Dividends Paid - Common rose 4.75% year-over-year to $3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.5 billion (up 4.86% YoY) and the FY2025 annual result came in at $12.4 billion, up 4.72% from the prior year.
- Dividends Paid - Common held at $3.1 billion in Q1 2026 per JNJ's latest filing, from $3.1 billion in the prior quarter.
- The five-year high for Dividends Paid - Common was $3.4 billion in Q1 2023, with the low at $2.8 billion in Q2 2022.
- Average Dividends Paid - Common over 5 years is $3.0 billion, with a median of $3.0 billion recorded in 2024.
- The widest YoY moves for Dividends Paid - Common: up 5.56% in 2023, down 16.74% in 2023.
- Johnson & Johnson's Dividends Paid - Common stood at $2.8 billion in 2022, then increased by 2.8% to $2.9 billion in 2023, then grew by 4.15% to $3.0 billion in 2024, then climbed by 4.93% to $3.1 billion in 2025, then changed by 0.0% to $3.1 billion in 2026.
- Business Quant data shows JNJ's Dividends Paid - Common at $3.1 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 3.13 Bn |
| Mar 29, 2026 | 3.13 Bn |
| Dec 28, 2025 | 3.13 Bn |
| Dec 28, 2025 | 3.13 Bn |
| Sep 28, 2025 | 3.13 Bn |
| Sep 28, 2025 | 3.13 Bn |
| Jun 29, 2025 | 3.13 Bn |
| Jun 29, 2025 | 3.13 Bn |
| Mar 30, 2025 | 2.99 Bn |
| Mar 30, 2025 | 2.99 Bn |
| Dec 29, 2024 | 2.98 Bn |
| Dec 29, 2024 | 2.98 Bn |
| Sep 29, 2024 | 2.99 Bn |
| Sep 29, 2024 | 2.99 Bn |
| Jun 30, 2024 | 2.99 Bn |
| Jun 30, 2024 | 2.99 Bn |
| Mar 31, 2024 | 2.87 Bn |
| Mar 31, 2024 | 2.87 Bn |
| Dec 31, 2023 | 2.87 Bn |
| Dec 31, 2023 | 2.87 Bn |